BlackRock’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-277,253
| Closed | -$63.7K | – | 5454 |
|
|
2024
Q4 | $63.7K | Buy |
277,253
+15,674
| +6% | +$3.6K | ﹤0.01% | 4835 |
|
|
2024
Q3 | $562K | Buy |
261,579
+2,390
| +0.9% | +$5.14K | ﹤0.01% | 4247 |
|
|
2024
Q2 | $1.34M | Buy |
259,189
+2,148
| +0.8% | +$11.1K | ﹤0.01% | 4040 |
|
|
2024
Q1 | $1.38M | Buy |
257,041
+10,097
| +4% | +$54K | ﹤0.01% | 4054 |
|
|
2023
Q4 | $1.92M | Buy |
246,944
+1,199
| +0.5% | +$9.34K | ﹤0.01% | 3978 |
|
|
2023
Q3 | $971K | Buy |
245,745
+34,681
| +16% | +$137K | ﹤0.01% | 4187 |
|
|
2023
Q2 | $665K | Buy |
211,064
+22,910
| +12% | +$72.2K | ﹤0.01% | 4320 |
|
|
2023
Q1 | $502K | Sell |
188,154
-19,565
| -9% | -$52.2K | ﹤0.01% | 4445 |
|
|
2022
Q4 | $746K | Sell |
207,719
-37,514
| -15% | -$135K | ﹤0.01% | 4424 |
|
|
2022
Q3 | $1.58M | Buy |
245,233
+92,802
| +61% | +$598K | ﹤0.01% | 4214 |
|
|
2022
Q2 | $1.47M | Sell |
152,431
-264,583
| -63% | -$2.55M | ﹤0.01% | 4292 |
|
|
2022
Q1 | $4.96M | Sell |
417,014
-6,213
| -1% | -$73.9K | ﹤0.01% | 3887 |
|
|
2021
Q4 | $13.8M | Sell |
423,227
-12,140
| -3% | -$396K | ﹤0.01% | 3423 |
|
|
2021
Q3 | $19.5M | Sell |
435,367
-10,969
| -2% | -$490K | ﹤0.01% | 3243 |
|
|
2021
Q2 | $24.3M | Buy |
446,336
+29,540
| +7% | +$1.61M | ﹤0.01% | 3132 |
|
|
2021
Q1 | $31.2M | Buy |
416,796
+84,240
| +25% | +$6.3M | ﹤0.01% | 2882 |
|
|
2020
Q4 | $36.1M | Buy |
332,556
+1,569
| +0.5% | +$170K | ﹤0.01% | 2628 |
|
|
2020
Q3 | $29.3M | Sell |
330,987
-1,303
| -0.4% | -$115K | ﹤0.01% | 2579 |
|
|
2020
Q2 | $35.4M | Buy |
332,290
+50,695
| +18% | +$5.4M | ﹤0.01% | 2419 |
|
|
2020
Q1 | $16.7M | Sell |
281,595
-4,746
| -2% | -$281K | ﹤0.01% | 2664 |
|
|
2019
Q4 | $19.8M | Buy |
286,341
+11,865
| +4% | +$820K | ﹤0.01% | 2852 |
|
|
2019
Q3 | $28.5M | Buy |
274,476
+7,760
| +3% | +$805K | ﹤0.01% | 2588 |
|
|
2019
Q2 | $24.7M | Buy |
266,716
+65,674
| +33% | +$6.08M | ﹤0.01% | 2709 |
|
|
2019
Q1 | $18.4M | Buy |
201,042
+2,429
| +1% | +$222K | ﹤0.01% | 2770 |
|
|
2018
Q4 | $11.1M | Buy |
198,613
+37,246
| +23% | +$2.07M | ﹤0.01% | 3018 |
|
|
2018
Q3 | $19.2M | Buy |
161,367
+3,004
| +2% | +$358K | ﹤0.01% | 2866 |
|
|
2018
Q2 | $16.2M | Buy |
158,363
+65,409
| +70% | +$6.68M | ﹤0.01% | 2955 |
|
|
2018
Q1 | $12.1M | Buy |
92,954
+35,459
| +62% | +$4.6M | ﹤0.01% | 3015 |
|
|
2017
Q4 | $5.59M | Buy |
57,495
+515
| +0.9% | +$50.1K | ﹤0.01% | 3362 |
|
|
2017
Q3 | $8.39M | Buy |
56,980
+2,527
| +5% | +$372K | ﹤0.01% | 3216 |
|
|
2017
Q2 | $8.76M | Buy |
54,453
+36,516
| +204% | +$5.88M | ﹤0.01% | 3208 |
|
|
2017
Q1 | $2.86M | Buy |
17,937
+17,912
| +71,648% | +$2.85M | ﹤0.01% | 3516 |
|
|
2016
Q4 | $3K | Buy |
+25
| New | +$3K | ﹤0.01% | 3550 |
|